Traders should monitor the upcoming earnings webcast on March 18 for potential insights into revenue, portfolio performance, or guidance. Absent material data, no immediate trading action is warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 12 $26.86entry
- T+1 · 8mo ago −1.79%α −1.19% · $26.38
- T+5 · 8mo ago +7.07%α +8.05% · $28.76
- T+20 · 7mo ago +36.78%α +34.81% · $36.74
- T+60 · 5mo ago +56.70%α +46.00% · $42.09
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
XOMA Royalty Corporation announced it will report its fourth quarter and full year 2025 financial results on March 18, 2026, followed by a webcast to discuss the results and provide a business update. The press release contains no actual financial data, only logistical details about the upcoming earnings announcement.
Key Facts
- XOMA Royalty Corporation will report Q4 and full year 2025 financial results on March 18, 2026.
- A webcast to discuss the results will be held the same day at 8:00 am Eastern Time.
- No financial figures or operational updates were disclosed in this release.
- The company is a biotech royalty aggregator with a portfolio of pre-commercial and commercial therapeutic candidates.
Financial Impact
No financial data disclosed in this release
Risk Factors
- Lack of disclosed financials limits ability to assess performance ahead of the release.
- Market may react negatively if actual results or guidance fall short of expectations during the webcast.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3254422 |
Track record
8 reports on XOMA
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +52.83% at T+60 after the Mar 18, 2026 report. 2 of 3 went positive at some point.
Filters
- Jul 27, 202616w ago 15-12G Bearish 7/10 No price data
- Jul 14, 202617w ago 8-K Bullish 8/10 Entry $40.17 to $40.17 · 0.00% +0.47% vs SPY
- Jun 12, 202622w ago DEFA14A Bullish 8/10 Entry $41.95 to $42.00 ▲ +0.12% +1.50% vs SPY
- Jun 12, 202622w ago 8-K Neutral 4/10 Entry $41.95 to $42.00 ▲ +0.12% +1.50% vs SPY
- Mar 18, 202634w ago Press Release Neutral 3/10 Entry $28.76 to $30.53 ▲ +6.15% +8.37% vs SPY
- Mar 18, 202634w ago 8-K Neutral 4/10 Entry $27.35 to $30.20 ▲ +10.42% +11.14% vs SPY
- Mar 18, 202634w ago Press Release Bullish 8/10 Entry $27.35 to $30.20 ▲ +10.42% +11.14% vs SPY
- Mar 12, 202635w ago Press Release Neutral 3/10 Viewing Entry $26.86 to $28.76 ▲ +7.07% +8.05% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers